Advertisement

Topics

Acorda reports five deaths in Parkinson's trial, shares plunge

04:35 EST 15 Nov 2017 | Reuters

(Reuters) - Acorda Therapeutics Inc said on Wednesday five people died in its Parkinson's disease drug trials, and it would stop enrolling new patients in two long-term safety studies, sending its shares down 34 percent in early trade.

Original Article: Acorda reports five deaths in Parkinson's trial, shares plunge

NEXT ARTICLE

More From BioPortfolio on "Acorda reports five deaths in Parkinson's trial, shares plunge"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...